Discovery of Highly Potent, Selective, Orally Bioavailable, Metabotropic Glutamate Subtype 5 (mGlu5) Receptor Antagonists Devoid of Cytochrome P450 1A2 Inhibitory Activity.

✍ Scribed by Nicholas D. Smith; et al. et al.

• Publisher: John Wiley and Sons
• Year: 2005
• Weight: 12 KB
• Volume: 36
• Category: Article
• ISSN: 0931-7597
• DOI: 10.1002/chin.200514231